During the past decade, Ohio State University Division of Nephrology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ohio State University Division of Nephrology" are "End Stage Renal Disease" (1 trials), "Lupus Erythematosus, Systemic" (1 trials) and "Lupus Nephritis" (1 trials). Many other conditions were trialed in "Ohio State University Division of Nephrology" in a lesser frequency.

Most popular intervention types in "Ohio State University Division of Nephrology" are "Drug" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Prednisone" (2 trials), "Acetaminophen" (1 trials), "Diphenhydramine" (1 trials) and "Graft placement surgery plus Trinam therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ohio State University Division of Nephrology" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Ohio State University Division of Nephrology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ohio State University Division of Nephrology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ohio State University Division of Nephrology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".